A substantial portion of biomedical R&D is publicly funded. But resulting medicines are typically covered by patents held by private firms, and priced without regard to the public's investment. The Bayh-Dole Act provides a possible remedy, but its scope is limited.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1017/jme.2021.7 | DOI Listing |
Publication Analysis
Top Keywords
realizing public
4
public rights
4
rights government
4
government patent
4
patent substantial
4
substantial portion
4
portion biomedical
4
biomedical r&d
4
r&d publicly
4
publicly funded
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!